Insider Selling: U.S. Physical Therapy, Inc. (NYSE:USPH) CFO Sells 516 Shares of Stock

U.S. Physical Therapy, Inc. (NYSE:USPH) CFO Carey P. Hendrickson sold 516 shares of the company’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the sale, the chief financial officer now owns 20,469 shares in the company, valued at approximately $1,970,141.25. This represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

U.S. Physical Therapy Price Performance

NYSE:USPH traded up $0.42 during midday trading on Monday, hitting $96.50. The company had a trading volume of 72,156 shares, compared to its average volume of 93,209. The company has a market capitalization of $1.46 billion, a PE ratio of 102.21, a P/E/G ratio of 4.34 and a beta of 1.46. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 52-week low of $76.18 and a 52-week high of $113.63. The stock’s fifty day moving average price is $88.04 and its 200-day moving average price is $90.09.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 15th were issued a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.82%. The ex-dividend date was Friday, November 15th. U.S. Physical Therapy’s payout ratio is currently 187.23%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on USPH. Bank of America reaffirmed a “neutral” rating and set a $90.00 target price (down previously from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Barrington Research reaffirmed an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a report on Thursday, November 21st. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Finally, JPMorgan Chase & Co. upped their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd.

Hedge Funds Weigh In On U.S. Physical Therapy

Institutional investors have recently modified their holdings of the company. Geode Capital Management LLC grew its holdings in shares of U.S. Physical Therapy by 1.3% during the 3rd quarter. Geode Capital Management LLC now owns 343,073 shares of the company’s stock valued at $29,040,000 after purchasing an additional 4,477 shares during the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in U.S. Physical Therapy during the third quarter valued at about $573,000. MML Investors Services LLC increased its holdings in shares of U.S. Physical Therapy by 12.7% in the third quarter. MML Investors Services LLC now owns 11,826 shares of the company’s stock worth $1,001,000 after buying an additional 1,329 shares during the period. Southernsun Asset Management LLC lifted its stake in shares of U.S. Physical Therapy by 10.5% in the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock valued at $46,302,000 after acquiring an additional 52,062 shares during the last quarter. Finally, State Street Corp lifted its stake in shares of U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after acquiring an additional 99,244 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.